253 related articles for article (PubMed ID: 7727765)
1. Telomerase activity in normal leukocytes and in hematologic malignancies.
Counter CM; Gupta J; Harley CB; Leber B; Bacchetti S
Blood; 1995 May; 85(9):2315-20. PubMed ID: 7727765
[TBL] [Abstract][Full Text] [Related]
2. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
El-Daly H; Kull M; Zimmermann S; Pantic M; Waller CF; Martens UM
Blood; 2005 Feb; 105(4):1742-9. PubMed ID: 15507522
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
5. Telomere dynamics and cytogenetic changes in human hematologic neoplasias: a working hypothesis.
Ohyashiki K; Ohyashiki JH
Cancer Genet Cytogenet; 1997 Mar; 94(1):67-72. PubMed ID: 9078293
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in human ovarian carcinoma.
Counter CM; Hirte HW; Bacchetti S; Harley CB
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2900-4. PubMed ID: 8159676
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
8. Development of retinoblastoma in the absence of telomerase activity.
Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
10. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
Lin TT; Letsolo BT; Jones RE; Rowson J; Pratt G; Hewamana S; Fegan C; Pepper C; Baird DM
Blood; 2010 Sep; 116(11):1899-907. PubMed ID: 20538793
[TBL] [Abstract][Full Text] [Related]
11. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
12. Changes in telomerase activity and telomere length during human T lymphocyte senescence.
Pan C; Xue BH; Ellis TM; Peace DJ; Díaz MO
Exp Cell Res; 1997 Mar; 231(2):346-53. PubMed ID: 9087176
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
14. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
Engelhardt M; Martens UM
Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
[TBL] [Abstract][Full Text] [Related]
15. [The opposite roles of telomerase during initiation and progression of cancers].
Brunori M; Gilson E
J Soc Biol; 2004; 198(2):105-11. PubMed ID: 15368958
[TBL] [Abstract][Full Text] [Related]
16. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
18. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
[TBL] [Abstract][Full Text] [Related]
19. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
[TBL] [Abstract][Full Text] [Related]
20. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
